On August 3, 2021 EVERSANA and other industry leaders reported at the PAP – Patient Assistance & Access Programs 2021 Virtual Event August 17–19 as we discuss how to break through affordability barriers to streamline operational complexities, enhance patient access and optimize stakeholder collaboration (Press release, EVERSANA, AUG 3, 2021, View Source [SID1234585599]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Backed by 22 years of content, PAP is the premier event for influential stakeholders to collaborate on how to further access to care, understand current changes in policy and optimize PAPs for better patient outcomes. With a blend of live and on-demand content, this three-day event is designed to provide you with the latest industry updates and opportunities to expand your network and collaborate with a multi-stakeholder audience.

EVERSANA is proud to participate in this year’s session, "Industry Disruptors — Stay on the Pulse of Trends in Co-pay Exclusions, Accumulators and Maximizers," featuring Joe Bachstadt, Vice President of Patient Services Affordability.

Joe Bachstadt

Vice President, Patient Services Affordability

On Thursday, August 19, at 1 pm EST, Joe will discuss the:

Evolution and current landscape of co-pay accumulator and maximizer models.
Patient and business impact of accumulators in the ability to access drugs, as well as the legal challenges.
New workarounds entering the market that are adding pressure to manufacturer PAPs.